The Olisa foundation was founded by Nzedegwu Robert Olisa, III in 2009 as a Texas based non-profit corporation. The foundation develops, and distributes Immunotherapeutics and provides cancer testing services in developing countries through a subsidiary called International Molecular Diagnostic Laboratories ®. Another independent subsidiary called American Journal of Biological Defense ® was founded in Washington DC in 2005. The journal publishes and organizes training to strengthen capacity for healthcare policy platforms in Sub-Saharan Africa and North/Central/ South America. A third independent subsidiary called Olisa Research, USA (formerly Biological Agents Corporation or BAC) was founded in 1998 in San Diego California as a Biochemical/Pharmaceutical Manufacturing and a research and development company. Collectively, all three subsidiaries work N'Sync to implement the foundations tripartite strategy for healthcare sustainability in addition to contagion and cancer risk management in emerging economies.